Inflammatory mechanisms are important in the pathogenesis of diseases throughout clinical medicine. To develop a further understanding of these diseases and allow improved diagnosis and treatment, we propose a program project entitled """"""""Molecular and Cellular Mechanisms of Human Inflammatory Diseases."""""""" This program project will be comprised of a series of highly collaborative and interactive projects with a clinical focus on inflammatory eye disease. These conditions are prevalent among systemic inflammatory diseases and illustrate well the involvement of major effector systems in inflammation. The pathogenetic and functional properties of various cell types in these ocular disorders will be investigated in conjunction with efforts to develop novel approaches to therapy. Reflecting this clinical focus, three closely related projects will investigate the role of the monocyte in inflammatory disease. These projects will explore the phenotypic and functional properties of monocytederived giant cells; the modification of murine mononuclear phagocyte cell function by monoclonal antibodies; and the biochemical processes in monocyte function as revealed by a series of novel purine nucleoside analogs. The program project will also investigate the immunochemical properties of a group of antibodies termed poly- specific. These antibodies bind more than one target antigen and mediate inflammatory damage by diverse effector mechanisms. The techniques of molecular cloning will be used to produce highly purified antigens of known sequence to define more precisely the nature of these binding interactions. Together, these studies unite clinical and basic investigators with a common interest in inflammation and immunoregulation and provide a mechanism for expanding their research into novel and clinically relevant directions.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Messina, J P; Gilkeson, G S; Pisetsky, D S (1993) The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol 147:148-57
Weinberg, J B; Wortham, T S; Misukonis, M A et al. (1993) Synovial mononuclear phagocytes in rheumatoid arthritis and osteoarthritis: quantitative and functional aspects. Immunol Invest 22:365-74
Robertson, C R; Gilkeson, G S; Ward, M M et al. (1992) Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus. Clin Immunol Immunopathol 62:25-32
Hale, L P; Haynes, B F (1992) Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 149:3809-16
Pincus, S H; Cole, R; Pisetsky, D S (1992) A defect in the humoral immune response to protein antigens and haptens in immunoglobulin mu heavy-chain transgenic mice. Mol Immunol 29:801-6
Pisetsky, D S (1992) Anti-DNA antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 18:437-54
Wu, S; Rodabaugh, K; Martinez-Maza, O et al. (1992) Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Am J Obstet Gynecol 166:997-1007
Gilkeson, G S; Spurney, R; Coffman, T M et al. (1992) Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol 64:166-72
Robertson, C R; Pisetsky, D S (1992) Specificity analysis of antibodies to single-stranded micrococcal DNA in the sera of normal human subjects and patients with systemic lupus erythematosus. Clin Exp Rheumatol 10:589-94
Weinberg, J B; Mason, S N (1991) Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression. Cancer Res 51:1202-9

Showing the most recent 10 out of 53 publications